Skip to content

Thoraflex™ Hybrid THP3036X150ARecalls & reported problems

Vascutek Ltd · Thoraflex Hybrid Plexus 4 Hybrid Stent Device · Class 3 · Implant

All models of Thoraflex Hybrid (33)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
3
Deaths reported
1
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 05037881026848), received between Jun 18, 2024 and Aug 18, 2025 — classified as 1 death, 2 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (2 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 1 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 1 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 1 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Adverse Event Without Identified Device or Use Problem2
  • Insufficient Device Problem Information2
  • Device Endoleak1

Patient problems

  • Insufficient Information2
  • Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available1
  • Multiple Organ Dysfunction Syndrome1
  • Obstruction/Occlusion1
  • Stroke/CVA1

Recent adverse event reports

The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.

  • DeathAug 18, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    THE PATIENT WAS ADMITTED ON (B)(6) 2024 AND DIED ON (B)(6) 2024. CAUSE OF DEATH IS CURRENTLY UNKNOWN.

    Patient problems: Insufficient Information; Multiple Organ Dysfunction Syndrome; Obstruction/Occlusion

    MAUDE report 22828025 ↗
  • InjuryApr 9, 2025Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information; Adverse Event Without Identified Device or Use Problem; Insufficient Device Problem Information

    EXTEND-001 (NCT05639400), SITE NO. (B)(4): ON POST OP DAY 1 SEDATION WAS WEANED OFF AND DID NOT WAKE UP AND WAS TAKEN FOR A HEAD CT SCAN WHICH DEMONSTRATED A RIGHT M2 OCCLUSION WITH EXTENSIVE INFARCT IN THE RIGHT MCA (MIDDLE CEREBRAL ARTERY), RIGHT PCA (POSTERIOR CEREBRAL ARTERY) AND RIGHT ACA (ANTERIOR CEREBRAL ARTERY) TERRITORIES. THE PATIENT CONDITION WORSENED ON POST OP DAY 5 AND WAS TAKEN FOR A REPEAT HCT (HEAD COMPUTED TOMOGRAPHY) SHOWING NEW MASS EFFECT OF THE RIGHT VENTRICLES AND EFFACEMENT WITH MIDLINE SHIFT FROM RIGHT TO LEFT WITH CONCERN FOR HERNIATION. NEUROSURGERY RECOMMENDED TO CONTINUE WITH MEDICAL MANAGEMENT. ON POST OPERATIVE DAY ONE (B)(6)2024), THE PATIENT HAD A SLOW EMERGENCE FROM SEDATION WEAN FOUND TO HAVE STROKES IN RIGHT MCA. HCT DEMONSTRATED "PROXIMAL RIGHT M2 MCA ANTERIOR DIVISION LARGE VESSEL OCCLUSION WITH INFARCT IN THE RIGHT MCA, PCA AND ACA TERRITORIES. MRS (MODIFIED RANKIN SCORE) ON (B)(6) 2024 WAS DOCUMENTED AS 0 (NO SYMPTOMS AT ALL). MRS ON (B)(6) 2024 (32 DAYS POST PROCEDURE) WAS 5 (SEVERE DISABILITY, BEDRIDDEN, INCONTINENT, REQUIRING CONSTANT NURSING CARE AND ATTENTION). SPINAL CORD ISCHAEMIA GUIDE ON (B)(6)2024 (32 DAYS POST PROCEDURE) WAS 3B (N

    Patient problems: Stroke/CVA

    MAUDE report 21805167 ↗
  • InjuryJun 18, 2024Device Endoleak; Device Endoleak

    AS REPORTED BY THE EXTEND-001 STUDY: IMPLANT DATE WAS (B)(6)2024, EVENT DATE WAS 16 MAY 24. EVENT REPORTED AS ENDOLEAK THROUGH THE EXISTING THORACIC ENDOVASCULAR AORTIC DEVICES. THORACIC ENDOVASCULAR AORTIC ANEURYSM REPAIR NOT INVOLVING LT SUBCLAVIAN ARTERY RELINES THE EXISTING DEVICES AND EXTEND TO TREAT THE POOR TRUE LUMEN EXPANSION IN THE DISTAL DESCENDING THORACIC AORTA. SURGICAL INTERVENTION WAS MARKED AS REQUIRED, BUT NO CONFIRMATION OF WHAT INTERVENTION WAS PERFORMED. PATIENT PRE-EXISTING CONDITIONS: HYPERTENSION, TYPE 2 DIABETES, ERECTILE DYSFUNCTION, AND PREVIOUS EMERGENT TYPE A DISSECTION REPAIR ASCENDING AORTA REPLACEMENT. THIS EVENT OCCURRED AFTER PROCEDURE AND THE PERIOD OF THE EVENT OCCURRED FOR 36 DAYS. THIS EVENT HAS BEEN MARKED AS DEVICE RELATED (WITHOUT DEVICE DEFICIENCY DESCRIPTION), POSSIBLY PROCEDURE RELATED AND NO INFORMATION IF IS RELATED TO PATIENT PREEXISTING CONDITION. PATIENT RECOVERED AND RESOLVED WITH TREATMENT ON (B)(6) 2024.

    Patient problems: Appropriate Clinical Signs, Symptoms and Conditions Term/Code Not Available; Insufficient Information

    MAUDE report 19556172 ↗

Other Hybrid stent graft, thoracic aortic lesion treatment devices

All Hybrid stent graft, thoracic aortic lesion treatment devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page